AAAAAA
Results:
1-9
|
Results: 9
Authors:
Zijlstra, EE
Nur, Y
Desjeux, P
Khalil, EAG
El-Hassan, AM
Groen, J
Citation: Ee. Zijlstra et al., Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan, TR MED I H, 6(2), 2001, pp. 108-113
Authors:
Wolday, D
Berhe, N
Akuffo, H
Desjeux, P
Britton, S
Citation: D. Wolday et al., Emerging Leishmania/HIV co-infection in Africa, MED MICROBI, 190(1-2), 2001, pp. 65-67
Authors:
Desjeux, P
Citation: P. Desjeux, Worldwide increasing risk factors for leishmaniasis, MED MICROBI, 190(1-2), 2001, pp. 77-79
Authors:
Rosenthal, E
Tempesta, S
Del Giudice, P
Marty, P
Desjeux, P
Pradier, C
Le Fichoux, Y
Cassuto, JP
Citation: E. Rosenthal et al., Declining incidence of visceral leishmaniasis in HIV-infected individuals in the era of highly active antiretroviral therapy, AIDS, 15(9), 2001, pp. 1184-1185
Authors:
Campbell-Lendrum, D
Dujardin, JP
Martinez, E
Feliciangeli, MD
Perez, JE
de Silans, LNMP
Desjeux, P
Citation: D. Campbell-lendrum et al., Domestic and peridomestic transmission of American cutaneous leishmaniasis: Changing epidemiological patterns present new control opportunities, MEM I OSW C, 96(2), 2001, pp. 159-162
Authors:
Desjeux, P
Citation: P. Desjeux, The increase in risk factors for leishmaniasis worldwide, T RS TROP M, 95(3), 2001, pp. 239-243
Authors:
Desjeux, P
Citation: P. Desjeux, Global control and leishmania HIV co-infection, CLIN DERMAT, 17(3), 1999, pp. 317-325
Authors:
Berhe, N
Wolday, D
Hailu, A
Abraham, Y
Ali, A
Gebre-Michael, T
Desjeux, P
Sonnerborg, A
Akuffo, H
Britton, S
Citation: N. Berhe et al., HIV viral load and response to antileishmanial chemotherapy in co-infectedpatients, AIDS, 13(14), 1999, pp. 1921-1925
Authors:
Boelaert, M
Lynen, L
Desjeux, P
Van der Stuyft, P
Citation: M. Boelaert et al., Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis, B WHO, 77(8), 1999, pp. 667-674
Risultati:
1-9
|